According to the longitudinal epidemiological studies, there have been elevated plasma insulin levels (Craft et al., 1998) in AD patients, with a close association between cognitive disorder and insulin resistance in T2DM patients (Arnold et al., 2018; Kshirsagar et al., 2021). This evidence concerns the gene INS and Alzheimer disease.